The prospect of GLP-1 analogues as major drugs for treatment of type 2 and perhaps also type 1 diabetes bears witness to this development and indicates that diabetes and obesity can be profoundly influenced by gastrointestinal hormones. The gene discussed is GCG; the disease is obesity disorder.